Are healthy guys who microdose GLP-1s smart early adopters of a blockbuster healthspan enhancement strategy
Grns works with Plus Capital, which invests in companies on behalf of its celebrity partners
Importantly, such variability does not negate biological relevance, but rather underscores the challenge of translating dynamic, context-sensitive endocrine signals into static biomarkers
The following search algorithm was applied: ((GLP-1 receptor agonist OR glucagon-like peptide-1 receptor agonist OR GIP receptor agonist OR glucose-dependent insulinotropic polypeptide OR liraglutide OR semaglutide OR dulaglutide OR tirzepatide) AND (body composition OR fat mass OR muscle mass OR lean mass OR adiposity OR body fat OR sarcopenia)) AND (clinical trial OR study OR randomized controlled trial OR RCT OR intervention study)
The GLP-1 Access Gap: Mapping Who Can Actually Afford Americas Miracle Weight-Loss Drugs Published 2/4/2026 Author: Andrew Reed, Assoc
Both come in varying dosage levels, ranging from 0.25 mg to 15 mg